Evidence map›Paper›PMID 29169361›Full record

ArticleBiomedical engineering online2017

Differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in fibrin scaffold by a histone deacetylase inhibitor.

Zahra Bagheri-Hosseinabadi, Parvin Salehinejad, Seyed Alireza Mesbah-Namin

Open access · goldAbstract read
In one paragraph

Article in Biomedical engineering online, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zahra Bagheri-HosseinabadiDepartment of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Parvin SalehinejadDepartment of Anatomy, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran. asalehinejad@yahoo.com.
Seyed Alireza Mesbah-NaminDepartment of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. mesbahna@modares.ac.ir.
Tarbiat Modares University · IRKerman University of Medical Sciences · IR

Funding

Kerman University of Medical Sciences 940646
6 · The paper itself

Abstract

backgroundHuman adipose-derived stem cells (hADSCs) are capable of differentiating into many cells such as cardiac cells. Different types of inducers are used for cardiac cell differentiation, but this question still remains to be investigated, which one is the best. The aim of this paper was to investigate the effect of combination of fibrin scaffold and trichostatin A (TSA), for differentiation of hADSCs into cardiomyocyte-like cells.

methodsAfter approval of characteristics of hADSCs and fibrin scaffold, hADSCs were cultured in fibrin scaffold with 10 µM TSA for 72 h and kept in standard conditions for 4 weeks. QRT-PCR and immunostaining assay were performed for evaluating the expression pattern of special cardiac genes and proteins.

resultsIn particular, our study showed that fibrin scaffold alongside TSA enhanced expression of the selected genes and proteins.

conclusionsWe concluded that the TSA alone or with fibrin scaffold can lead to the generation of cardiac like cells in a short period of time.

Indexed as

Adipose TissueCell CycleCell DifferentiationDrug InteractionsFemaleFibrinHistone Deacetylase InhibitorsHumansHydroxamic AcidsMiddle AgedMyocytes, CardiacStem CellsFibrinHistone Deacetylase InhibitorsHydroxamic Acidstrichostatin ACardiomyocyte-like cellsDifferentiationFibrin scaffoldHuman ADSCsTSA

Identifiers

PMID29169361
PMCPMC5701346
OpenAlexW2770447010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.